Cited by 137Helicobacter pylori-related gastroenterology studiesAntibiotic Resistance in BacteriaBacterial Genetics and Biotechnology

16S rRNA Mutation-Mediated Tetracycline Resistance in Helicobacter pylori

Open access
Gerrits, Monique M., de Zoete, Marcel R., Arents, Niek L. A., Kuipers, Ernst J., Kusters, Johannes G.·2002·Antimicrobial Agents and Chemotherapy

Abstract

Most Helicobacter pylori strains are susceptible to tetracycline, an antibiotic commonly used for the eradication of H. pylori . However, an increase in incidence of tetracycline resistance in H. pylori has recently been reported. Here the mechanism of tetracycline resistance of the first Dutch tetracycline-resistant (Tet r ) H. pylori isolate (strain 181) is investigated. Twelve genes were selected from the genome sequences of H. pylori strains 26695 and J99 as potential candidate genes, based on their homology with tetracycline resistance genes in other bacteria. With the exception of the two 16S rRNA genes, none of the other putative tetracycline resistance genes was able to transfer tetracycline resistance. Genetic transformation of the Tet s strain 26695 with smaller overlapping PCR fragments of the 16S rRNA genes of strain 181, revealed that a 361-bp fragment that spanned nucleotides 711 to 1071 was sufficient to transfer resistance. Sequence analysis of the 16S rRNA genes of the Tet r strain 181, the Tet s strain 26695, and four Tet r 26695 transformants showed that a single triple-base-pair substitution, AGA 926-928 →TTC, was present within this 361-bp fragment. This triple-base-pair substitution, present in both copies of the 16S rRNA gene of all our Tet r H. pylori transformants, resulted in an increased MIC of tetracycline that was identical to that for the Tet r strain 181.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/aac.46.9.2996-3000.2002

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • 16S rRNA mutations seen in H. pylori and P. acnes that confer resistance to tetracycline are in close proximity to the primary binding site.

    “(v) 16S rRNA mutations seen in H. pylori (19, 55) and P. acnes (40) that confer resistance to tetracycline are in close proximity to the primary binding site.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 30 · Cited by 137

Authors
Gerrits, M. M., de Zoete, M. R., Arents, N. L. A., Kuipers, E. J., & Kusters, J. G.
Affiliations
  • Erasmus MC (NL)
  • Department of Gastroenterology and Hepatology, Erasmus MC—University Medical Center Rotterdam, Rotterdam
  • University of Groningen (NL)
Corresponding author
Kusters, Johannes G.
Venue
Antimicrobial Agents and Chemotherapy
Published
2002-09
Volume
46
Issue
9
Pages
2996-3000
ISSN
  • 0066-4804 (ISSN-L)
  • 1098-6596
OpenAlex
W2136315497
Cited by
137
References
30
Citations by year
2026: 4 · 2025: 4 · 2024: 10 · 2023: 8 · 2022: 7 · 2021: 9 · 2020: 3 · 2019: 8 · 2018: 6 · 2017: 3 · 2016: 8 · 2015: 7 · 2014: 7 · 2013: 2 · 2012: 2
FWCI
7.93
Type
journal article
Language
en
Open access
Locations
  • Antimicrobial Agents and Chemotherapy (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
  • RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Surgery › Helicobacter pylori-related gastroenterology studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Antibiotic Resistance in Bacteria
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
Keywords
Helicobacter pylori, tetracycline resistance, antibiotic resistance mechanisms, genetic transformation, H. pylori eradication therapy
MeSH terms
Aged, Binding Sites, Humans, Male, Mutation, Repressor Proteins, RNA, Ribosomal, 16S, Tetracycline Resistance, Transformation, Bacterial, Helicobacter pylori, Helicobacter Infections, Amino Acid Substitution, Reverse Transcriptase Polymerase Chain Reaction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review